• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利水痘带状疱疹病毒感染的流行病学

The epidemiology of Varicella Zoster Virus infection in Italy.

作者信息

Gabutti Giovanni, Rota Maria C, Guido Marcello, De Donno Antonella, Bella Antonino, Ciofi degli Atti Marta L, Crovari Pietro

机构信息

Department of Clinical and Experimental Medicine, Section of Hygiene and Occupational Health, University of Ferrara, Ferrara, Italy.

出版信息

BMC Public Health. 2008 Oct 27;8:372. doi: 10.1186/1471-2458-8-372.

DOI:10.1186/1471-2458-8-372
PMID:18954432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2601043/
Abstract

BACKGROUND

The epidemiological importance of varicella and zoster and the availability of an efficacious and safe vaccine have led to an important international debate regarding the suitability of mass vaccination. The objective of the study was to describe the epidemiology of varicella and zoster in Italy and to determine whether there have been changes with respect to observations provided by an analogous study conducted 8 years ago, in order to define the most appropriate vaccination strategy.

METHODS

A number of data sources were evaluated, a cross-sectional population-based seroprevalence study was conducted on samples collected in 2004, and the results were compared with data obtained in 1996.

RESULTS

The data from active and passive surveillance systems confirm that varicella is a widespread infectious disease which mainly affects children. VZV seroprevalence did not substantially differ from that found in the previous study. The sero-epidemiological profile in Italy is different from that in other European countries. In particular, the percentage of susceptible adolescents is at least nearly twice as high as in other European countries and in the age group 20-39 yrs, approximately 9% of individuals are susceptible to VZV.

CONCLUSION

The results of this study can contribute to evaluating the options for varicella vaccination. It is possible that in a few years, in all Italian Regions, there will exist the conditions necessary for implementing a mass vaccination campaign and that the large-scale availability of MMRV tetravalent vaccines will facilitate mass vaccination.

摘要

背景

水痘和带状疱疹的流行病学重要性以及有效且安全疫苗的可得性引发了一场关于大规模疫苗接种适用性的重要国际辩论。本研究的目的是描述意大利水痘和带状疱疹的流行病学情况,并确定与8年前进行的一项类似研究的观察结果相比是否有变化,以便确定最合适的疫苗接种策略。

方法

评估了多个数据来源,对2004年收集的样本进行了一项基于人群的横断面血清流行率研究,并将结果与1996年获得的数据进行比较。

结果

主动和被动监测系统的数据证实,水痘是一种广泛传播的传染病,主要影响儿童。水痘带状疱疹病毒(VZV)血清流行率与先前研究中的结果没有实质性差异。意大利的血清流行病学特征与其他欧洲国家不同。特别是,易感青少年的比例至少比其他欧洲国家高出近两倍,在20至39岁年龄组中,约9%的个体对VZV易感。

结论

本研究结果有助于评估水痘疫苗接种的选择。几年内,意大利所有地区可能具备开展大规模疫苗接种运动的必要条件,并且MMRV四价疫苗的大规模可得性将促进大规模疫苗接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/04c438b5b395/1471-2458-8-372-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/1eb1d6d1176c/1471-2458-8-372-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/b6246edab6c1/1471-2458-8-372-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/ea3e97f0a9b2/1471-2458-8-372-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/04c438b5b395/1471-2458-8-372-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/1eb1d6d1176c/1471-2458-8-372-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/b6246edab6c1/1471-2458-8-372-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/ea3e97f0a9b2/1471-2458-8-372-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aef/2601043/04c438b5b395/1471-2458-8-372-4.jpg

相似文献

1
The epidemiology of Varicella Zoster Virus infection in Italy.意大利水痘带状疱疹病毒感染的流行病学
BMC Public Health. 2008 Oct 27;8:372. doi: 10.1186/1471-2458-8-372.
2
Seroprevalence of varicella-zoster virus in Polish population.波兰人群中水痘-带状疱疹病毒的血清流行率。
Przegl Epidemiol. 2009;63(4):495-9.
3
Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.在大规模使用水痘疫苗之前以色列水痘带状疱疹的血清流行病学。
Infection. 2006 Aug;34(4):208-13. doi: 10.1007/s15010-006-6604-4.
4
[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].[模拟疫苗接种对水痘带状疱疹病毒流行病学的影响]
Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31.
5
Varicella zoster virus infection occurs at a relatively young age in The Netherlands.水痘带状疱疹病毒感染在荷兰发生于相对年轻的年龄。
Vaccine. 2013 Oct 17;31(44):5127-33. doi: 10.1016/j.vaccine.2013.08.029. Epub 2013 Aug 22.
6
Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.台湾0至12岁儿童水痘带状疱疹病毒易感性相关因素分析
Med Mal Infect. 2007 Apr;37(4):222-8. doi: 10.1016/j.medmal.2006.10.013. Epub 2007 Mar 26.
7
Varicella zoster virus transmission dynamics in Vojvodina, Serbia.塞尔维亚伏伊伏丁那水痘-带状疱疹病毒传播动力学。
PLoS One. 2018 Mar 5;13(3):e0193838. doi: 10.1371/journal.pone.0193838. eCollection 2018.
8
Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland.芬兰水痘-带状疱疹病毒的基因分型分析及其血清流行率
Clin Vaccine Immunol. 2007 Sep;14(9):1057-61. doi: 10.1128/CVI.00348-06. Epub 2007 Jul 11.
9
Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.意大利医护人员和医学生水痘血清阳性率调查。
Hum Vaccin Immunother. 2021 Feb 1;17(2):372-376. doi: 10.1080/21645515.2020.1771989. Epub 2020 Jul 9.
10
The epidemiological situation of chickenpox in the Silesian voivodeship in the years 2011-2015 in view of data of the situation in Poland.基于波兰水痘疫情数据,分析2011 - 2015年西里西亚省的水痘流行病学情况。
Przegl Epidemiol. 2016;70(4):555-562.

引用本文的文献

1
The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020-2070).意大利 50 年来(2020-2070 年)水痘疫苗覆盖率地区差异相关的临床和经济成本。
Sci Rep. 2024 May 24;14(1):11929. doi: 10.1038/s41598-024-60649-8.
2
Sero-Epidemiological Study of Varicella in the Italian General Population.意大利普通人群水痘的血清流行病学研究。
Vaccines (Basel). 2023 Jan 30;11(2):306. doi: 10.3390/vaccines11020306.
3
A Deep Learning Approach to Estimate the Incidence of Infectious Disease Cases for Routinely Collected Ambulatory Records: The Example of Varicella-Zoster.

本文引用的文献

1
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.欧洲区域11个国家水痘带状疱疹病毒的比较血清流行病学研究。
Vaccine. 2007 Nov 7;25(45):7866-72. doi: 10.1016/j.vaccine.2007.07.036. Epub 2007 Aug 8.
2
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?意大利中部育龄妇女对水痘的易感性:是否有必要为这一人群接种疫苗?
Vaccine. 2007 Aug 10;25(32):6086-8. doi: 10.1016/j.vaccine.2007.05.019. Epub 2007 Jun 4.
3
[Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes].
深度学习方法估算常规收集的门诊记录中传染病病例的发生率:以水痘-带状疱疹为例。
Int J Environ Res Public Health. 2022 May 13;19(10):5959. doi: 10.3390/ijerph19105959.
4
Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy.儿童临床和流行病学水痘负担随时间有变化吗?意大利2010年至2017年住院治疗、合并症及费用概述。
Vaccines (Basel). 2021 Dec 15;9(12):1485. doi: 10.3390/vaccines9121485.
5
Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.意大利医护人员和医学生水痘血清阳性率调查。
Hum Vaccin Immunother. 2021 Feb 1;17(2):372-376. doi: 10.1080/21645515.2020.1771989. Epub 2020 Jul 9.
6
Hepatitis B Seroprevalence in the Pediatric and Adolescent Population of Florence (Italy): An Update 27 Years after the Implementation of Universal Vaccination.意大利佛罗伦萨儿童及青少年人群中的乙肝血清流行率:普遍接种疫苗27年后的最新情况
Vaccines (Basel). 2020 Mar 30;8(2):156. doi: 10.3390/vaccines8020156.
7
Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia.塞尔维亚伏伊伏丁那地区水痘带状疱疹病毒感染的血清流行病学研究。
Epidemiol Infect. 2018 Sep;146(12):1593-1601. doi: 10.1017/S0950268818001619. Epub 2018 Jun 18.
8
Management of chickenpox in pregnant women: an Italian perspective.孕妇水痘的管理:意大利的观点。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1603-1609. doi: 10.1007/s10096-018-3286-7. Epub 2018 May 25.
9
A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data.对欧洲国家在儿童普遍免疫接种之前水痘血清流行率的系统评价:从血清流行率数据推导发病率
Epidemiol Infect. 2017 Oct;145(13):2666-2677. doi: 10.1017/S0950268817001546. Epub 2017 Aug 22.
10
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.在实施儿童普遍免疫接种之前欧洲水痘负担的估计。
BMC Infect Dis. 2017 May 18;17(1):353. doi: 10.1186/s12879-017-2445-2.
[2001 - 2003年意大利轮状病毒肠胃炎相关住院情况,通过国际疾病分类第九版临床修正版(ICD9 - CM)诊断编码进行评估]
Ig Sanita Pubbl. 2006 Mar-Apr;62(2):215-44.
4
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.荷兰水痘和带状疱疹的流行病学:对水痘带状疱疹病毒疫苗接种的影响。
Vaccine. 2006 May 1;24(18):3946-52. doi: 10.1016/j.vaccine.2006.02.017. Epub 2006 Feb 24.
5
Varicella immunization and herpes zoster.水痘免疫接种与带状疱疹
Herpes. 2005 Dec;12(3):59.
6
Impact of varicella vaccination on health care utilization.水痘疫苗对医疗保健利用的影响。
JAMA. 2005 Aug 17;294(7):797-802. doi: 10.1001/jama.294.7.797.
7
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.一种预防老年人带状疱疹及带状疱疹后神经痛的疫苗。
N Engl J Med. 2005 Jun 2;352(22):2271-84. doi: 10.1056/NEJMoa051016.
8
Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.美国儿童水痘疫苗接种情况:1995 - 2005年首个十年后的评估
J Clin Virol. 2005 Jun;33(2):89-95; discussion 96-8. doi: 10.1016/j.jcv.2005.02.003.
9
Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002.1992 - 2002年水痘疫苗接种后水痘发病率下降前后的带状疱疹发病率
J Infect Dis. 2005 Jun 15;191(12):2002-7. doi: 10.1086/430325. Epub 2005 May 12.
10
Preventing varicella-zoster disease.预防水痘-带状疱疹疾病。
Clin Microbiol Rev. 2005 Jan;18(1):70-80. doi: 10.1128/CMR.18.1.70-80.2005.